Assessment of safety and antihypertensive efficacy of a cardioselective beta-blocker nebivolbl in patients with hypertension and concomitant chronic obstructive bronchitis

被引：0
|
作者：
Yakushin, SS [1 ]
Okorokov, VG
Liferov, RA
Fomina, VA
Ivanova, GO
机构：
[1] IP Pavlov Med Univ, Ryazan, Russia
[2] Ryazan Reg Clin Hlth Ctr, Ryazan, Russia
来源：
KARDIOLOGIYA | 2002年 / 42卷 / 11期
关键词：
hypertension; treatment; nebivolol; chronic obstructive bronchitis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Safety, tolerability and antihypertensive efficacy of a cardioselective beta-blocker nebivolol was studied in 30 patients with mild and moderate hypertension and concomitant stage 1 chronic obstructive bronchitis. Nebivolol (5 mg/day) was given for 1 month; in 5 patients complementary hydrochlorothiazide (12.5 mg/day) was required for sufficient. antihypertensive effect. Nebivolol was well tolerated (only 1 patient complained of head ache), did not cause worsening of bronchitis and spirometric parameters, exerted no cardiodepressive action, and did not induce apparent disturbances of metabolism.
引用
收藏
页码：36 / 39
页数：4
相关论文
共 50 条
  • [21] The prognostic impact of beta-blocker therapy in patients with left ventricular dysfunction and chronic obstructive pulmonary disease
    Kleemann, T
    Kilkowski, A
    Bangert, M
    Lindner, K
    Siegler, K
    Senges, J
    Bergmeier, C
    EUROPEAN HEART JOURNAL, 2001, 22 : 264 - 264
  • [22] THE EFFICACY OF BETA-BLOCKER IN PATIENTS WITH PAROXYSMAL ATRIAL-FIBRILLATION - ASSESSMENT BY BAROREFLEX SENSITIVITY MEASUREMENT
    YAMAGUCHI, I
    KURIHARA, T
    MAEDA, H
    ENDOH, M
    NIHO, B
    KUGA, K
    SUGISHITA, Y
    CIRCULATION, 1993, 88 (04) : 445 - 445
  • [23] Beta-blocker efficacy for intra- and interdialytic hypertension patients: a systematic review and meta-analysis
    Hartono, Eugenia Maria Alodia
    Saputra, Felicia Fransisca
    Permata, Angeline Asti Shiela
    Wibowo, Jeanne Gabrielle
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (07) : 2279 - 2289
  • [24] Beta-blocker use in patients with chronic obstructive pulmonary disease: A systematic reviewti A systematic review of βB in COPD
    Ruzieh, Mohammed
    Baugh, Aaron D.
    Al Jebbawi, Lama
    Edwards, Emily S.
    Jia, Kelly Qi
    Dransfield, Mark T.
    Foy, Andrew J.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2023, 33 (01) : 53 - 61
  • [25] THE USE OF BETA BLOCKER NEBIVOLOL IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN ASSOCIATION WITH ARTERIAL HYPERTENSION
    Martiniuc, C.
    Branishte, T.
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2012, 116 (01): : 218 - 221
  • [26] Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice
    Stefan Perings
    Georg Stöckl
    Malte Kelm
    Advances in Therapy, 2016, 33 : 1550 - 1564
  • [27] Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice
    Perings, Stefan
    Stoeckl, Georg
    Kelm, Malte
    ADVANCES IN THERAPY, 2016, 33 (09) : 1550 - 1564
  • [28] The use of selective beta-adrenoblocker bisoprolol in patients with acute myocardial infarction and concomitant chronic obstructive bronchitis
    Terestchenko, SN
    Pavlikova, EP
    Sivkov, VI
    Moiseev, VS
    KARDIOLOGIYA, 2000, 40 (09) : 42 - 44
  • [29] Comparative safety of beta-blocker and calcium channel blockers in patients with chronic obstructive pulmonary disease and atrial fibrillation: A national population cohort study in Taiwan
    Lin, Shan-Ju
    Chen, Nai-Yu
    Chang, Yu-Ching
    Cheng, Ching-Lan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 272 - 272
  • [30] ANTIHYPERTENSIVE EFFICACY OF THE CALCIUM-ANTAGONIST FELODIPINE IN PATIENTS WITH PERSISTING HYPERTENSION ON BETA-ADRENOCEPTOR BLOCKER THERAPY
    LEENEN, FHH
    LOGAN, AG
    MYERS, MG
    ELKAN, I
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (05) : 535 - 545
12345